Application of syringa pubescens extract in preparation of medicine for treating hepatitis

The invention belongs to the technical field of traditional Chinese medicine, and particularly relates to application of syringa pubescens extract in preparation of medicine for treating hepatitis, and the syringa pubescens extract is syringa pubescens ethyl acetate extract. The syringa pubescens flower part is extracted from the syringa pubescens ethyl acetate extract. The hepatitis is non-alcoholic steatohepatitis (NASH), and is characterized in that the hepatitis is a non-alcoholic steatohepatitis (NASH). Research results show that the syringa pubescens ethyl acetate extract (SPE) can improve the non-alcoholic steatohepatitis from multiple aspects such as lipid accumulation, oxidative stress and inflammation by activating an Nrf2/HO-1 pathway and inhibiting an I kappa B alpha/NF kappa B pathway..

Medienart:

Patent

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Europäisches Patentamt - (2024) vom: 05. Jan. Zur Gesamtaufnahme - year:2024

Sprache:

Englisch

Beteiligte Personen:

WU YANFANG [VerfasserIn]
XU WEIDONG [VerfasserIn]
WANG CHENYU [VerfasserIn]
ZHANG SUYA [VerfasserIn]
GUAN XINYI [VerfasserIn]
ZHANG ZICHEN [VerfasserIn]
WANG XINSHENG [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2024-01-05, Last update posted on www.tib.eu: 2024-03-25, Last updated: 2024-03-29

Patentnummer:

CN117338836

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA001077635